Weight-loss drugs based on GLP-1 receptor agonists are delivering levels of weight reduction earlier difficult to achieve.

Wegovy pill prescriptions have now topped 2 million since January, including 1.3 million during Q1 alone. ・CEO Mike Doustdar said that Wegovy is “the most efficacious GLP-1 tablet” and is already used ...

As GLP-1 receptor agonists reshape obesity treatment, a new medical perspective published in the Journal of the American ...

The medication, typically used for weight loss or diabetes treatment, is showing promise curbing cravings for alcohol and ...

ICOTYDE™ (icotrokinra) approved by FDA in March for moderate-to-severe plaque psoriasis, triggering a $50 million ...

The number of bariatric surgeries performed annually in the U.S. has taken a sharp drop lately, new research shows, ...

Drawing on electronic health records from nearly 20 million patients with severe obesity, researchers from University of ...

Rhode Island’s governor also has proposed removing GLP-1 coverage from the state’s Medicaid program for weight loss treatment ...

Ozempic is now available in pill form for people with type 2 diabetes. Novo Nordisk says the oral GLP-1's new lower-dose ...

Drawing on electronic health records from nearly 20 million patients with severe obesity, researchers from University of ...

People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and ...

We don’t treat other chronic illnesses as a personal failing. Doctors should focus on medicine, not morality. | Opinion ...